Novo Nordisk Pharmaceuticals has the research, development and manufacturing unit in Denmark and supplies their medicines across Australia and New Zealand. The company manufactures NovoSeven RT for activating and curing blood clots and other bleeding troubles.
NovoSeven RT drug is in the powder form of white in colour and this can be diluted in any liquid for the intake. The package of this powder is done in a glass vial for visibility. The glass vial should not be replaced again, once the initial powder is emptied. The vial must be immediately disposed in a proper condition. The company has made outer protective plastic capped layers for the packing and commutation convenience.
The main ingredient of this powder is recombinant coagulation factor VIIa (rFVIIa) and the other composition includes polysorbate 80, sodium chloride, glycylglycine, calcium chloride, sucrose and dehydrates. This vial comes in different unit packages such as 1 mg, 2 mg or 5 mg.
Itching, nausea, fever, vomiting, uneven heart beats, blood clotting and tremors are some of the side effects that result in some people and they are advised to consult the doctor immediately. This powder should be preserved only in the glass vial and can be stored in any syringes.